Published in Nanomedicine on November 06, 2010
Development of macromolecular prodrug for rheumatoid arthritis. Adv Drug Deliv Rev (2012) 1.07
Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation. Mol Pharm (2013) 0.94
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci (2014) 0.81
Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells. Eur J Pharm Biopharm (2015) 0.80
A dendrimer-based immunosensor for improved capture and detection of tumor necrosis factor-α cytokine. Anal Chim Acta (2012) 0.76
Dendrimer-coupled sonophoresis-mediated transdermal drug-delivery system for diclofenac. Drug Des Devel Ther (2015) 0.75
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med (2012) 3.43
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today (2010) 2.03
The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials (2008) 1.74
Neddylation of a breast cancer-associated protein recruits a class III histone deacetylase that represses NFkappaB-dependent transcription. Nat Cell Biol (2006) 1.62
NAD+-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. J Biol Chem (2009) 1.43
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm (2003) 1.36
Alpha-4 integrins and VCAM-1, but not MAdCAM-1, are essential for recruitment of mast cell progenitors to the inflamed lung. Blood (2006) 1.32
Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery. Biomaterials (2009) 1.29
Mutations in ABCB6 cause dyschromatosis universalis hereditaria. J Invest Dermatol (2013) 1.21
Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines. Bioconjug Chem (2006) 1.19
Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels. Bioconjug Chem (2008) 1.13
Diverse cellular and apoptotic responses to variant shapes of UHMWPE particles in a murine model of inflammation. Biomaterials (2002) 1.12
Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload. Biomaterials (2005) 1.11
Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration. Biomaterials (2011) 1.10
Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine (2013) 1.09
Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates. Bioconjug Chem (2005) 1.09
Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration. Nanomedicine (Lond) (2010) 1.04
The comparative effects of lipid, epinephrine, and their combination in the reversal of bupivacaine-induced asystole in the isolated rat heart. Anesth Analg (2011) 1.02
Nanotechnology approaches for ocular drug delivery. Middle East Afr J Ophthalmol (2013) 1.00
Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers. Int J Pharm (2010) 1.00
Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis. Mol Pharm (2012) 0.99
Drug release characteristics of PAMAM dendrimer-drug conjugates with different linkers. Int J Pharm (2009) 0.98
Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation. Mol Pharm (2011) 0.96
Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest. ACS Nano (2014) 0.96
Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells. J Biomater Sci Polym Ed (2004) 0.96
The inflammatory response after an epidermal burn depends on the activities of mouse mast cell proteases 4 and 5. J Immunol (2010) 0.95
Agrobacterium tumefaciens-mediated transformation of Withania somnifera (L.) Dunal: an important medicinal plant. Plant Cell Rep (2009) 0.95
Affinity-based selection of regulatory T cells occurs independent of agonist-mediated induction of Foxp3 expression. J Immunol (2009) 0.94
Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation. Mol Pharm (2013) 0.94
Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates. Biomaterials (2010) 0.93
Dendrimer-enabled transformation of Chlamydia trachomatis. Microb Pathog (2013) 0.91
Transfer of PAMAM dendrimers across human placenta: prospects of its use as drug carrier during pregnancy. J Control Release (2010) 0.91
Inhibitors of ROS production by the ubiquinone-binding site of mitochondrial complex I identified by chemical screening. Free Radic Biol Med (2013) 0.91
Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers. Angew Chem Int Ed Engl (2013) 0.90
miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses. Immunology (2014) 0.90
Dendrimer nanoparticles for ocular drug delivery. J Ocul Pharmacol Ther (2013) 0.89
Stem cells as potential therapeutic targets for inflammatory bowel disease. Front Biosci (Schol Ed) (2010) 0.87
Efficacy of periprosthetic erythromycin delivery for wear debris-induced inflammation and osteolysis. Inflamm Res (2010) 0.87
Improvement in ductility of chitosan through blending and copolymerization with PEG: FTIR investigation of molecular interactions. Biomacromolecules (2003) 0.87
Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications. Biomacromolecules (2010) 0.86
cDNA cloning, gene organization and variant specific expression of HIF-1 alpha in high altitude yak (Bos grunniens). Gene (2006) 0.86
Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. Bone (2008) 0.86
WsSGTL1 gene from Withania somnifera, modulates glycosylation profile, antioxidant system and confers biotic and salt stress tolerance in transgenic tobacco. Planta (2014) 0.85
Lipid emulsion reverses bupivacaine-induced asystole in isolated rat hearts: concentration-response and time-response relationships. Anesthesiology (2010) 0.83
Effects of branching architecture and linker on the activity of hyperbranched polymer-drug conjugates. Bioconjug Chem (2009) 0.83
Expression and functional activity of pro-oxidants and antioxidants in murine heart exposed to acute hypobaric hypoxia. FEBS Lett (2007) 0.83
Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice. Mol Hum Reprod (2004) 0.82
Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis. Inflamm Res (2009) 0.82
Synthesis, characterization, and in vitro activity of dendrimer-streptokinase conjugates. Bioconjug Chem (2007) 0.82
Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches. Arthritis (2012) 0.81
The roles of monocytic heat shock protein 60 and Toll-like receptors in the regional inflammation response to wear debris particles. J Biomed Mater Res A (2010) 0.81
The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease. Int Rev Immunol (2013) 0.81
Coaxial PCL/PVA electrospun nanofibers: osseointegration enhancer and controlled drug release device. Biofabrication (2013) 0.81
Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application. Int J Nanomedicine (2011) 0.80
[Relation between Beta-2-glycoprotein I and hepatitis B virus surface antigen]. Zhonghua Gan Zang Bing Za Zhi (2002) 0.80
Leptin antagonist ameliorates chronic colitis in IL-10⁻/⁻ mice. Immunobiology (2013) 0.80
Supercritical carbon dioxide processed resorbable polymer nanocomposite bone graft substitutes. Acta Biomater (2011) 0.80
Enhancing the efficacy of Ara-C through conjugation with PAMAM dendrimer and linear PEG: a comparative study. Biomacromolecules (2013) 0.79
Impacts of age and gender on bone marrow profiles of BMP7, BMPRs and Stro-1⁺ cells in patients with total hip replacement. Int Orthop (2011) 0.79
Differentiation of septic and aseptic loosening by PET with both 11C-PK11195 and 18F-FDG in rat models. Nucl Med Commun (2012) 0.79
The severity of experimental autoimmune cystitis can be ameliorated by anti-CXCL10 Ab treatment. PLoS One (2013) 0.79
Hydroxyl PAMAM dendrimer-based gene vectors for transgene delivery to human retinal pigment epithelial cells. Nanoscale (2015) 0.78
The bactericidal and biocompatible characteristics of reinforced calcium phosphate cements. Biomed Mater (2012) 0.78
PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections. Nanomedicine (2011) 0.78
Generation and staining of intestinal stem cell lineage in adult midgut. Methods Mol Biol (2012) 0.78
Infection in Orthopaedics. J Orthop Trauma (2015) 0.78
Engineering strength, porosity, and emission intensity of nanostructured CdSe networks by altering the building-block shape. J Am Chem Soc (2008) 0.77
Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation. J Control Release (2009) 0.77
Poly(vinyl alcohol)/collagen/hydroxyapatite hydrogel: properties and in vitro cellular response. J Biomed Mater Res A (2012) 0.77
Low-energy electron-induced single strand breaks in 2'-deoxycytidine-3'-monophosphate using the local complex potential based time-dependent wave packet approach. J Phys Chem A (2011) 0.77
Alternative medicines as emerging therapies for inflammatory bowel diseases. Int Rev Immunol (2012) 0.77
Concurrent quantification of tryptophan and its major metabolites. Anal Biochem (2013) 0.77
Transcriptional downregulation of sterol metabolism genes in murine liver exposed to acute hypobaric hypoxia. Biochem Biophys Res Commun (2006) 0.77
A novel alkali metals/strontium co-substituted calcium polyphosphate scaffolds in bone tissue engineering. J Biomed Mater Res B Appl Biomater (2011) 0.76
A dendrimer-based immunosensor for improved capture and detection of tumor necrosis factor-α cytokine. Anal Chim Acta (2012) 0.76
Electrospun polyvinyl alcohol-collagen-hydroxyapatite nanofibers: a biomimetic extracellular matrix for osteoblastic cells. Nanotechnology (2012) 0.76
Chronic follicular bronchiolitis requires antigen-specific regulatory T cell control to prevent fatal disease progression. J Immunol (2013) 0.75
Electronic structure analysis and electron detachment energies of polynitrogen pentagonal aromatic anions. J Phys Chem A (2006) 0.75
Immunological response to bolus versus multiple injections of hylan G-F 20 (Synvisc) in a murine biocompatibility model. J Biomed Mater Res B Appl Biomater (2014) 0.75
[Comparison of ultrasound and nerve stimulation techniques for brachial plexus block for regional hemodynamic changes of upper extremity]. Zhonghua Yi Xue Za Zhi (2013) 0.75
Investigation of dissociative electron attachment to 2'-deoxycytidine-3'-monophosphate using DFT method and time dependent wave packet approach. J Chem Phys (2012) 0.75
Spectral assignments for the aldose reductase inhibitor 4(S)-2,3-dihydro-6-fluoro-2(R)-methylspiro[chroman-4,4'-imidazoline]-2',5'-dione and its synthetic intermediates. Magn Reson Chem (2005) 0.75
Facile synthesis of ultrasmall GdF3 nanowires via an oriented attachment growth and their luminescence properties. Chem Commun (Camb) (2011) 0.75
Simple systematization of vibrational excitation cross-section calculations for resonant electron-molecule scattering in the boomerang and impulse models. J Chem Phys (2007) 0.75